help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malle, E.
Right arrow Articles by Grone, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malle, E.
Right arrow Articles by Grone, H. J.

American Journal of Pathology, Vol 150, 603-615, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Immunological evidence for hypochlorite-modified proteins in human kidney

E Malle, C Woenckhaus, G Waeg, H Esterbauer, EF Grone and HJ Grone
Karl-Franzens University Graz, Germany.

Oxygen radicals and oxidatively modified proteins seem to participate in degenerative vascular and inflammatory diseases. Factors that contribute to the development of atherosclerosis, eg, oxidation of low- density lipoproteins (LDLs), may also contribute to glomerulosclerosis. Although the nature of the in vivo oxidants remains unknown, recent findings indicated that the myeloperoxidase (MPO)-H2O2-halide system could play an important role in modification of (lipo)proteins in human tissues. MPO, the enzyme responsible for hypochlorite (HOCl/OCl-) formation, is present in human atherosclerotic lesions and in inflammatory conditions. In the present study, MPO was identified by Western blot analysis and immunohistochemical technique in diseased human kidney either with primarily sclerotic or inflammatory lesions. Furthermore, the presence of HOCl-modified proteins was demonstrated in diseased renal tissues using a specific monoclonal antibody (clone 2D10G9), raised against HOCl-modified LDL, that does not cross-react with native LDL or Cu(2+)-, 4-hydroxynonenal-, or malondialdehyde- modified LDL. The antibody recognized HOCl-modified proteins in glomerular and tubulointerstitial inflammatory and fibrotic lesions and pronounced immunostaining was demonstrated in mononuclear cells. LDL or human serum albumin oxidized by HOCl in vitro, but not native LDL or human serum albumin, effectively competed with epitopes in diseased kidney for antibody binding. Western blot analysis in diseased kidney protein samples revealed at least two major proteins recognized by the anti-HOCl-modified protein monoclonal antibody. Densitometric evaluation of immunoreactive bands obtained under these conditions demonstrated that expression of HOCl-modified proteins is tightly coupled to expression of immunoreactive MPO in the same tissue samples. From our studies it is proposed that oxidation of proteins by HOCl might be a leading event in glomerular and tubulointerstitial injury. By this mechanism, mononuclear cells, a permanent source for MPO, may play a key role in the development of nephrosclerosis, glomerulo- clerosis, and tubulointerstitial fibrosis, respectively.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
X. Deng, J. Lu, L. D. Lehman-McKeeman, E. Malle, D. L. Crandall, P. E. Ganey, and R. A. Roth
p38 Mitogen-Activated Protein Kinase-Dependent Tumor Necrosis Factor-{alpha}-Converting Enzyme Is Important for Liver Injury in Hepatotoxic Interaction between Lipopolysaccharide and Ranitidine
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 144 - 152.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy
Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Deng, J. P. Luyendyk, W. Zou, J. Lu, E. Malle, P. E. Ganey, and R. A. Roth
Neutrophil Interaction with the Hemostatic System Contributes to Liver Injury in Rats Cotreated with Lipopolysaccharide and Ranitidine
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Hasegawa, Y. Ito, J. Wijeweera, J. Liu, E. Malle, A. Farhood, R. S. McCuskey, and H. Jaeschke
Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1385 - G1395.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Odobasic, A. R. Kitching, T. J. Semple, and S. R. Holdsworth
Endogenous Myeloperoxidase Promotes Neutrophil-Mediated Renal Injury, but Attenuates T Cell Immunity Inducing Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 760 - 770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Hasegawa, E. Malle, A. Farhood, and H. Jaeschke
Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning
Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G760 - G767.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. J. Klebanoff
Myeloperoxidase: friend and foe
J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. S. Gujral, J. A. Hinson, A. Farhood, and H. Jaeschke
NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G243 - G252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Porubsky, H. Schmid, M. Bonrouhi, M. Kretzler, E. Malle, P. J. Nelson, and H.-J. Grone
Influence of Native and Hypochlorite-Modified Low-Density Lipoprotein on Gene Expression in Human Proximal Tubular Epithelium
Am. J. Pathol., June 1, 2004; 164(6): 2175 - 2187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Marsche, R. Zimmermann, S. Horiuchi, N. N. Tandon, W. Sattler, and E. Malle
Class B Scavenger Receptors CD36 and SR-BI Are Receptors for Hypochlorite-modified Low Density Lipoprotein
J. Biol. Chem., November 28, 2003; 278(48): 47562 - 47570.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
U. M. Hanumegowda, B. L. Copple, M. Shibuya, E. Malle, P. E. Ganey, and R. A. Roth
Basement Membrane and Matrix Metalloproteinases in Monocrotaline-Induced Liver Injury
Toxicol. Sci., November 1, 2003; 76(1): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Marsche, A. Hammer, O. Oskolkova, K. F. Kozarsky, W. Sattler, and E. Malle
Hypochlorite-modified High Density Lipoprotein, a High Affinity Ligand to Scavenger Receptor Class B, Type I, Impairs High Density Lipoprotein-dependent Selective Lipid Uptake and Reverse Cholesterol Transport
J. Biol. Chem., August 23, 2002; 277(35): 32172 - 32179.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. E. Brown, E. M. Brunt, and J. W. Heinecke
Immunohistochemical Detection of Myeloperoxidase and Its Oxidation Products in Kupffer Cells of Human Liver
Am. J. Pathol., December 1, 2001; 159(6): 2081 - 2088.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Gwinner and H.-J. Grone
Role of reactive oxygen species in glomerulonephritis
Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1127 - 1132.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Scheuer, W. Gwinner, J. Hohbach, E. F. Grone, R. P. Brandes, E. Malle, C. J. Olbricht, A. K. Walli, and H.-J. Grone
Oxidant stress in hyperlipidemia-induced renal damage
Am J Physiol Renal Physiol, January 1, 2000; 278(1): F63 - F74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Pullar, C. C. Winterbourn, and M. C. M. Vissers
Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1505 - H1512.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. J. I. RAATS, M. E. LUCA, M. A. H. BAKKER, A. VAN DER WAL, P. HEERINGA, H. VAN GOOR, J. VAN DEN BORN, E. DE HEER, and J. H. M. BERDEN
Reduction in Glomerular Heparan Sulfate Correlates with Complement Deposition and Albuminuria in Active Heymann Nephritis
J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1689 - 1699.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Panzenboeck, S. Raitmayer, H. Reicher, H. Lindner, O. Glatter, E. Malle, and W. Sattler
Effects of Reagent and Enzymatically Generated Hypochlorite on Physicochemical and Metabolic Properties of High Density Lipoproteins
J. Biol. Chem., November 21, 1997; 272(47): 29711 - 29720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Nuszkowski, R. Grabner, G. Marsche, A. Unbehaun, E. Malle, and R. Heller
Hypochlorite-modified Low Density Lipoprotein Inhibits Nitric Oxide Synthesis in Endothelial Cells via an Intracellular Dislocalization of Endothelial Nitric-oxide Synthase
J. Biol. Chem., April 20, 2001; 276(17): 14212 - 14221.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.